• Title/Summary/Keyword: Crossed hemiplegia

Search Result 2, Processing Time 0.014 seconds

Anatomical Findings of Hemiplegia Cruciata in Multiple Sclerosis (다발성 경화증에서 교대성편마비의 해부학적 소견)

  • Jeong, Hye Young;Chung, Eun Joo;Kim, Eung Gyu;Bae, Jong Seok
    • Annals of Clinical Neurophysiology
    • /
    • v.16 no.1
    • /
    • pp.39-41
    • /
    • 2014
  • Hemiplegia cruciata (HC) manifests as paralysis of the ipsilateral arm and contralateral leg. Herein, we report a 64-year-old man with weakness of the right leg and of the left arm after multiple sclerosis (MS). His brain and spine magnetic resonance imaging show a lower medulla lesion, which is extended to posterior part of C1 spine through cervicomedullary junction. HC usually results from stroke or trauma, but it is rare as presenting symptom of MS.

Approach of Proprioceptive Neuromuscular Facilitation on Foot drop and Crossing Obstacles in stroke patient: Case report (뇌졸중 환자의 장애물 보행능력 향상과 하수족 개선을 위한 고유수용성신경근촉진법의 적용: 증례보고)

  • Song, Gui-Bin
    • PNF and Movement
    • /
    • v.13 no.2
    • /
    • pp.111-118
    • /
    • 2015
  • Purpose: The purpose of this study was to describe the effects of proprioceptive neuromuscular facilitation (PNF) on episodes of foot drop and the ability to cross obstacles in stoke patients. Methods: The patient was a 57-year-old man with left hemiplegia. This patient displayed episodes of foot drop while walking and issues with crossing obstacles. The patient underwent therapeutic exercises and occupational therapy twice daily at a hospital five times a week. The patient was treated with PNF outside of these therapeutic sessions. Each session, which was 60 minutes in length, was conducted 3 times a week over 8 weeks. Over the course of treatment, a pre-test and post-test were completed. The patient walked for a test time of 6M. During the testing process, the patient crossed obstacles. In addition, the number of foot drop episodes was recorded. Each test was measured three times to determine the mean value. Results: After the PNF treatments, the number of foot drop episodes decreased from five to one. The 6M walking test time during which the patient crossed obstacles also decreased from 18 seconds to 10 seconds. Conclusion: The use of PNF treatments is beneficial to reduce the number of foot drop episodes while walking and to improve the ability to cross obstacles in stroke patients.